H.I.G. Capital
Deals on record
1
Common Fundraising Type
Series C
On Target Laboratories
Biotechnology
On Target Laboratories develops and commercializes FDA-approved imaging agents for cancer surgeries, using near-infrared dye and targeting molecules to aid in detecting and resecting cancer cells.